Patent · US Active

Anti-B7-H3 antibodies and antibody drug conjugates

US10640563B2 · kind B2 · utility

2Cited by

155References

3Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Lorenzo Benatuil · Northborough, US
Debra Chao · Fremont, US
Kamel Izeradjene · Gurnee, US
Andrew S. Judd · Grayslake, US
Andrew C. Phillips · Libertyville, US
Andrew J. Souers · Libertyville, US
Archana Thakur · Pleasanton, US

Key dates

Filing date	Jun 7, 2017
Grant date	May 5, 2020
Priority date	—
Expiry date	Aug 31, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to B7 homology 3 protein (B7-H3) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.